Over the last 25 years usage of pharmaceuticals has increased amongst our elderly, and consequentially the number of pharmaceutical injuries has risen due to fualty usage. On average about eight people die and another 500 are hospitalized in Sweden every day due to fualty usage of prescription medication.
Our goal is to give all people tools to live a satisfactory life at home, reduce the pain and suffering for patients and their relatives, as well as ease the pressure on the health care sector.
MediRätt was founded in 2008 and is publicly traded on Nasdaq First North since 2016.
MediRätt has developed the Dosell product, as well as a range of apps that together form a unique overarching concept that ensures that the sick and elderly receive safe and reliable treatment.
MediRätt has developed an app that seamlessly and simply provides patients information about side effects, reactions and allergies linked to different drugs. The app was launched for iPhone as well as Android during December 2016.
MediRätt has transfered its share listing from Aktietorget to the NASDAQ First North in Stockholm. Please see the investor relations pages on this website for more information.